W. Haigh, D. Guralski, L. Arrigo, J. Letsinger, Michele V. Clarke, R. MacIsaac, G. Jerums, D. L. Very
{"title":"Development of a Novel Polyclonal Antibody-Based Immunoassay for the Quantitation of Non-Albumin Urinary Proteins","authors":"W. Haigh, D. Guralski, L. Arrigo, J. Letsinger, Michele V. Clarke, R. MacIsaac, G. Jerums, D. L. Very","doi":"10.2174/1874241601306010001","DOIUrl":null,"url":null,"abstract":"Background:\n Better diagnostic methods to detect urinary proteinuria or albuminuria, important indicators of\ndiabetic kidney disease, are needed. Here, we describe the development and performance qualification of a new immunoassay\nfor the quantitation of non-albumin urinary proteins of 20 to 90 kilodaltons.\n Methods:\n Urinary proteins, purified from pooled, 24-hour, diabetic urines, were immunoabsorbed to remove albumin,\nelectrophoretically characterized, and identified by mass spectrometry. Sheep anti-urinary protein polyclonal antibodies\nwere immunoabsorbed to remove albumin reactivity. Major immunoreactive specificities of the polyclonal antibody were\nidentified by Western blot. A polyclonal antibody-based competitive immunoassay was developed and performanceevaluated.\nAn unpaired t-test (α = 0.05) and a receiver-operating characteristic curve were used to evaluate the measurement\nof 24-hour urinary protein excretion rates in distinguishing between normal, proteinuric, and albuminuric samples.\n Results:\n Approximately 380 mg of urinary protein was purified from 6.0 g of total urinary proteins. Mass spectrometry\nidentified more than 36 different proteins in the purified preparation. The anti-urinary protein polyclonal antibody possessed\nsignificant immunoreactivity towards transferrin, IgG chains, alpha-1-acid glycoprotein, zinc-alpha-2-glycoprotein,\nprostaglandin-H2-d-isomerase, and alpha-1-microglobulin. The competitive immunoassay exhibited excellent analytical\nand clinical performance. Measurement of urinary protein excretion rates could distinguish between normoproteinuric and\nproteinuric samples (p < 0.0001; area under the curve = 0.6900) and between normoalbuminuric and albuminuric samples\n(p < 0.0001; area under the curve = 0.8782).\n Conclusion:\n Measurement of urinary protein excretion rates using the urinary protein immunoassay is clinically equivalent\nto laboratory methods of quantitating total urinary protein or albumin in identifying proteinuria and albuminuria.","PeriodicalId":112973,"journal":{"name":"The Open Clinical Chemistry Journal","volume":"30 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2013-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Open Clinical Chemistry Journal","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/1874241601306010001","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 1
Abstract
Background:
Better diagnostic methods to detect urinary proteinuria or albuminuria, important indicators of
diabetic kidney disease, are needed. Here, we describe the development and performance qualification of a new immunoassay
for the quantitation of non-albumin urinary proteins of 20 to 90 kilodaltons.
Methods:
Urinary proteins, purified from pooled, 24-hour, diabetic urines, were immunoabsorbed to remove albumin,
electrophoretically characterized, and identified by mass spectrometry. Sheep anti-urinary protein polyclonal antibodies
were immunoabsorbed to remove albumin reactivity. Major immunoreactive specificities of the polyclonal antibody were
identified by Western blot. A polyclonal antibody-based competitive immunoassay was developed and performanceevaluated.
An unpaired t-test (α = 0.05) and a receiver-operating characteristic curve were used to evaluate the measurement
of 24-hour urinary protein excretion rates in distinguishing between normal, proteinuric, and albuminuric samples.
Results:
Approximately 380 mg of urinary protein was purified from 6.0 g of total urinary proteins. Mass spectrometry
identified more than 36 different proteins in the purified preparation. The anti-urinary protein polyclonal antibody possessed
significant immunoreactivity towards transferrin, IgG chains, alpha-1-acid glycoprotein, zinc-alpha-2-glycoprotein,
prostaglandin-H2-d-isomerase, and alpha-1-microglobulin. The competitive immunoassay exhibited excellent analytical
and clinical performance. Measurement of urinary protein excretion rates could distinguish between normoproteinuric and
proteinuric samples (p < 0.0001; area under the curve = 0.6900) and between normoalbuminuric and albuminuric samples
(p < 0.0001; area under the curve = 0.8782).
Conclusion:
Measurement of urinary protein excretion rates using the urinary protein immunoassay is clinically equivalent
to laboratory methods of quantitating total urinary protein or albumin in identifying proteinuria and albuminuria.